[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100551956":3},{"organization":4,"armGroups":7,"interventions":7,"overallOfficials":8,"centralContacts":13,"locations":7,"responsibleParty":23,"collaborators":7,"id":25,"slug":26,"hasResults":27,"nctId":28,"briefTitle":29,"officialTitle":30,"acronym":7,"eligibilityCriteria":31,"healthyVolunteers":27,"sex":32,"minAge":33,"maxAge":7,"enrollmentInfo":34,"targetDuration":7,"studyType":37,"phases":7,"briefSummary":38,"conditions":39,"keywords":41,"overallStatus":43,"whyStopped":7,"lastUpdateSubmitDate":44,"lastUpdatePostDateStruct":45,"startDateStruct":48,"completionDateStruct":50,"leadSponsor":52,"locationsCount":7},{"fullName":5,"class":6},"Gruppo Italiano Malattie EMatologiche dell'Adulto","OTHER",null,[9],{"name":10,"affiliation":11,"role":12},"Nicola Vianelli","UO Ematologia AOU Policlinico S.Orsola-Malpighi di Bologna","PRINCIPAL_INVESTIGATOR",[14,19],{"name":15,"role":16,"phone":17,"phoneExt":7,"email":18},"Paola Fazi","CONTACT","0670390528","p.fazi@gimema.it",{"name":20,"role":16,"phone":21,"phoneExt":7,"email":22},"Enrico Crea","0670390514","e.crea@gimema.it",{"type":24,"investigatorFullName":7,"investigatorTitle":7,"investigatorAffiliation":7,"oldNameTitle":7,"oldOrganization":7},"SPONSOR","100551956","observational-study-on-the-outcome-of-patients-with-itp-who-underwent-splenectomy-after-2010-100551956",false,"NCT06466824","Observational Study on the Outcome of Patients With ITP Who Underwent Splenectomy After 2010","Observational Study on the Outcome of Patients With Primary Immune Thrombocytopenia (ITP) Who Underwent Splenectomy After January 1st, 2010","Inclusion Criteria:\n\n* Patients aged ≥ 18 years\n* Patients with primary ITP according to international criteria \\[2\\], who underwent to splenectomy from 01\u002F01\u002F2010 to 12\u002F31\u002F2022.\n* Obtaining Informed Consent.\n\nExclusion Criteria:\n\n* none","ALL","18 Years",{"count":35,"type":36},157,"ESTIMATED","OBSERVATIONAL","Retrospective data collection on ITP patients who underwent splenectomy from 01\u002F01\u002F2010 to 12\u002F31\u002F2022. The expected enrollment period is 6 months. The observation period of the enrolled patients is at least 1 year.",[40],"Primary Immune Thrombocytopenia",[42],"splenectomy","NOT_YET_RECRUITING","2024-06-14",{"date":46,"type":47},"2024-06-20","ACTUAL",{"date":49,"type":36},"2024-09",{"date":51,"type":36},"2025-03",{"name":5,"class":6}]